Rhumbline Advisers Abb Vie Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Abb Vie Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 3,162,161 shares of ABBV stock, worth $622 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

3,162,161

Previous 3,255,511 2.87%

Holding current value

$622 Million

Previous $593 Million 8.51%

% of portfolio

0.52%

Previous 0.58%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $14.4 Million - $16.9 Million	-93,350 Reduced 2.87%	3,162,161 $542 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $4.36 Million - $4.97 Million	-27,308 Reduced 0.83%	3,255,511 $593 Million
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $2.27 Million - $2.55 Million	16,469 Added 0.5%	3,282,819 $509 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $3.11 Million - $3.6 Million	23,250 Added 0.72%	3,266,350 $487 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $9.73 Million - $12.1 Million	73,451 Added 2.32%	3,243,100 $437 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $24.6 Million - $28.3 Million	170,080 Added 5.67%	3,169,649 $505 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $16.1 Million - $19.3 Million	116,421 Added 4.04%	2,999,569 $485 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $13.2 Million - $15.1 Million	98,281 Added 3.53%	2,883,148 $387 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $13.9 Million - $17.6 Million	100,697 Added 3.75%	2,784,867 $427 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $2.16 Million - $2.68 Million	16,348 Added 0.61%	2,684,170 $435 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $4.05 Million - $5.12 Million	37,662 Added 1.43%	2,667,822 $361 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $5.46 Million - $6.2 Million	-51,334 Reduced 1.91%	2,630,160 $284 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $16 Million - $17.8 Million	-151,918 Reduced 5.36%	2,681,494 $302 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $16.4 Million - $18.1 Million	-160,379 Reduced 5.36%	2,833,412 $307 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $4.31 Million - $5.82 Million	-53,584 Reduced 1.76%	2,993,791 $321 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $2.33 Million - $2.73 Million	27,064 Added 0.9%	3,047,375 $267 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $51.4 Million - $68.8 Million	700,976 Added 30.22%	3,020,311 $297 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $299,086 - $453,452	4,637 Added 0.2%	2,319,335 $177 Million
Q4 2019 Feb 05, 2020	SELL	$72.13 - $90.25 $2.13 Million - $2.67 Million	-29,539 Reduced 1.26%	2,314,698 $205 Million
Q3 2019 Oct 23, 2019	BUY	$62.98 - $75.72 $1.49 Million - $1.79 Million	23,679 Added 1.02%	2,344,237 $178 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $4.81 Million - $6.15 Million	-73,248 Reduced 3.06%	2,320,558 $169 Million
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $6.36 Million - $7.49 Million	82,463 Added 3.57%	2,393,806 $193 Million
Q4 2018 Jan 31, 2019	SELL	$77.85 - $96.01 $710,848 - $876,667	-9,131 Reduced 0.39%	2,311,343 $213 Million
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $8.23 Million - $9.15 Million	-92,562 Reduced 3.84%	2,320,474 $219 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $3.17 Million - $3.76 Million	-35,356 Reduced 1.44%	2,413,036 $224 Million
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $5.04 Million - $6.75 Million	-54,752 Reduced 2.19%	2,448,392 $232 Million
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $5.24 Million - $5.75 Million	58,509 Added 2.39%	2,503,144 $242 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $171 Million - $218 Million	2,444,635	2,444,635 $217 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Abb Vie Inc. Transaction History